Hmdb loader
Show more...Show more...Show more...
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2019-08-20 15:16:49 UTC
Update Date2022-03-07 03:18:16 UTC
HMDB IDHMDB0240386
Secondary Accession NumbersNone
Metabolite Identification
Common NameCangrelor
DescriptionCangrelor (trade name: Kengreal (US), Kengrexal (Europe)) is a P2Y12 antagonist FDA approved as an antiplatelet drug that is administered intravenously to reduce ischemic events (i.e. restricted blood flow) in patients undergoing percutaneous coronary intervention (PCI). PCI, also known as coronary angioplasty, is a nonsurgical procedure which opens blocked or narrowed coronary arteries that are clogged due to a buildup of plaque. Being an adenosine triphosphate (ATP) analogue, cangrelor is able to bind the adenosine diphosphate (ADP) receptor P2Y12 and inhibit ADP-mediated platelet activation and aggregation. An advantage cangrelor provides over oral P2Y12 inhibitors (e.g. clopidogrel, ticagrelor, ticlopidine, and prasugrel) is that it is an active drug not requiring hepatic conversion, therefore, providing a rapid onset and offset of action (PMID: 27729681 ).
Structure
Thumb
Synonyms
ValueSource
KengrealHMDB
AR-C69931MXHMDB
AR C69931MXHMDB
N(6)-(2-Methylthioethyl)-2-(3,3,3-trifluoropropylthio)-5'-adenylic acid monoanhydride with dichloromethylenebis(phosphonic acid)HMDB
Cangrelor tetrasodiumHMDB
KengrexalHMDB
CangrelorMeSH
Chemical FormulaC17H25Cl2F3N5O12P3S2
Average Molecular Weight776.35
Monoisotopic Molecular Weight774.9483145
IUPAC Name[dichloro({[({[(2R,3S,4R,5R)-3,4-dihydroxy-5-(6-{[2-(methylsulfanyl)ethyl]amino}-2-[(3,3,3-trifluoropropyl)sulfanyl]-9H-purin-9-yl)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl})methyl]phosphonic acid
Traditional Namecangrelor
CAS Registry Number163706-06-7
SMILES
CSCCNC1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)C(Cl)(Cl)P(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC(SCCC(F)(F)F)=N1
InChI Identifier
InChI=1S/C17H25Cl2F3N5O12P3S2/c1-43-5-3-23-12-9-13(26-15(25-12)44-4-2-16(20,21)22)27(7-24-9)14-11(29)10(28)8(38-14)6-37-42(35,36)39-41(33,34)17(18,19)40(30,31)32/h7-8,10-11,14,28-29H,2-6H2,1H3,(H,33,34)(H,35,36)(H,23,25,26)(H2,30,31,32)/t8-,10-,11-,14-/m1/s1
InChI KeyPAEBIVWUMLRPSK-IDTAVKCVSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as phenolic glycosides. These are organic compounds containing a phenolic structure attached to a glycosyl moiety. Some examples of phenolic structures include lignans, and flavonoids. Among the sugar units found in natural glycosides are D-glucose, L-Fructose, and L rhamnose.
KingdomOrganic compounds
Super ClassOrganic oxygen compounds
ClassOrganooxygen compounds
Sub ClassCarbohydrates and carbohydrate conjugates
Direct ParentPhenolic glycosides
Alternative Parents
Substituents
  • Phenolic glycoside
  • O-glucuronide
  • 1-o-glucuronide
  • Glucuronic acid or derivatives
  • Hexose monosaccharide
  • O-glycosyl compound
  • Phenoxy compound
  • Phenol ether
  • Beta-hydroxy acid
  • Benzenoid
  • Pyran
  • Oxane
  • Monosaccharide
  • Hydroxy acid
  • Monocyclic benzene moiety
  • Secondary alcohol
  • Oxacycle
  • Organoheterocyclic compound
  • Organic 1,3-dipolar compound
  • Propargyl-type 1,3-dipolar organic compound
  • Polyol
  • Monocarboxylic acid or derivatives
  • Carboxylic acid
  • Carboxylic acid derivative
  • Carboximidic acid derivative
  • Carboximidic acid
  • Acetal
  • Organic nitrogen compound
  • Organopnictogen compound
  • Organic oxide
  • Hydrocarbon derivative
  • Primary alcohol
  • Organonitrogen compound
  • Carbonyl group
  • Alcohol
  • Aromatic heteromonocyclic compound
Molecular FrameworkAromatic heteromonocyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
Predicted Chromatographic Properties
Spectra
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
Not Available
Abnormal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Unstable angina
details
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB06441
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID8029718
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkCangrelor
METLIN IDNot Available
PubChem Compound9854012
PDB IDNot Available
ChEBI ID90841
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Baker DE, Ingram KT: Cangrelor. Hosp Pharm. 2015 Nov;50(10):922-929. doi: 10.1310/hpj5010-922. Epub 2015 Nov 19. [PubMed:27729681 ]